Neurogene Inc. short interest in 2018
In 2018, Neurogene Inc.'s disclosed short interest ran from 1.12% of shares outstanding on 12 Jan 2018 to 0.99% on 31 Dec 2018, a change of -0.13 percentage points. The year's high was 3.19% on 29 Jun 2018 and its low 0.64% on 30 Nov 2018, averaging 1.35% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.89 days on 15 Jun 2018. Full history: Neurogene Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 1.12% (12 Jan 2018)
- End of year
- 0.99% (31 Dec 2018)
- Change
- -0.13 pp
- High
- 3.19% (29 Jun 2018)
- Low
- 0.64% (30 Nov 2018)
- Average
- 1.35%
- Highest days to cover
- 4.89 (15 Jun 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 1.12% | 3.83 | |
| 31 Jan 2018 | 1.17% | 2.57 | |
| 15 Feb 2018 | 1.36% | 1.71 | |
| 28 Feb 2018 | 1.40% | 2.51 | |
| 15 Mar 2018 | 1.29% | 2.94 | 10-K filed, results (8-K) |
| 29 Mar 2018 | 1.29% | 3.66 | |
| 13 Apr 2018 | 1.05% | 2.99 | |
| 30 Apr 2018 | 1.13% | 4.66 | |
| 15 May 2018 | 1.25% | 3.90 | 10-Q filed, results (8-K) |
| 31 May 2018 | 1.68% | 3.42 | |
| 15 Jun 2018 | 2.31% | 4.89 | |
| 29 Jun 2018 | 3.19% | 1.00 | |
| 31 Jul 2018 | 2.12% | 1.00 | |
| 15 Aug 2018 | 1.33% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 0.90% | 1.00 | |
| 14 Sep 2018 | 1.45% | 1.64 | |
| 28 Sep 2018 | 1.48% | 2.12 | |
| 15 Oct 2018 | 1.52% | 1.89 | |
| 31 Oct 2018 | 0.83% | 1.43 | |
| 15 Nov 2018 | 0.85% | 1.99 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 0.64% | 1.00 | |
| 14 Dec 2018 | 0.72% | 2.28 | |
| 31 Dec 2018 | 0.99% | 2.05 |
See also: Neurogene Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.